Skin cancer in the PUVA-48 cooperative study

Henry H. Roenigk*, William A. Caro

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

54 Scopus citations


A 4-year follow-up study of 631 patients with psoriasis given 8-methoxypsoralen and UVA in the PUVA-48 cooperative study revealed only ten patients with skin cancer and eight patients with actinic keratosis. The skin cancer group averaged 14 years older than the group without lesions. The cumulative treatment ranged from 255 to 1,737 joules/cm2 at the time of development of skin cancer. The ratio of basal cell carcinoma to squamous cell carcinoma and the anatomic location of lesions generally follow the pattern of spontaneously developing lesions. Ionizing radiation was a significant risk factor, but previous arsenic exposure or skin cancer was not. Comparison with previous studies and lack of control population may indicate less risk of skin cancer following PUVA than previously suggested.

Original languageEnglish (US)
Pages (from-to)319-324
Number of pages6
JournalJournal of the American Academy of Dermatology
Issue number3
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Skin cancer in the PUVA-48 cooperative study'. Together they form a unique fingerprint.

Cite this